INS and metabolic dysfunction-associated steatotic liver disease: Our findings showed that treatment with WEA (0.8 and 1.6 g/kg BW) induced a significant decrease in serum GLU and insulin levels, suggesting that reduction of serum GLU might not possibly be related to the reduced serum insulin levels in WEA-treated rats with NAFLD.